A. Maggio

Pretreatment patient‐specific IMRT quality assurance: A correlation study between gamma index and patient clinical dose volume histogram

M. Stasi, S. Bresciani, A. Miranti et al. · Medical Physics · 2012 · 210 citations

Relationships between bladder dose–volume/surface histograms and acute urinary toxicity after radiotherapy for prostate cancer

V. Carillo, C. Cozzarini, T. Rancati et al. · Radiotherapy and Oncology · 2014 · 48 citations

Radiation Medicine, Urology, Radiation Therapy +7

Tomotherapy treatment plan quality assurance: The impact of applied criteria on passing rate in gamma index method

S. Bresciani, A. Di Dia, A. Maggio et al. · Medical Physics · 2013 · 41 citations

Daily Sodium Butyrate Enema for the Prevention of Radiation Proctitis in Prostate Cancer Patients Undergoing Radical Radiation Therapy: Results of a Multicenter Randomized Placebo-Controlled Dose-Finding Phase 2 Study

A. Maggio, Alessandro Magli, T. Rancati et al. · International Journal of Radiation Oncology*Biology*Physics · 2014 · 40 citations

Urology, Radiation Medicine, Surgical Oncology +6

Comparison of two different EPID-based solutions performing pretreatment quality assurance: 2D portal dosimetry versus 3D forward projection method

S. Bresciani, M. Poli, A. Miranti et al. · Physica Medica · 2018 · 33 citations

Measurement, Medicine, Different Epid-based Solutions +7